CLEARMIND MEDICINE INC (CMND) Stock News

USA - NASDAQ:CMND - CA1850534027 - Common Stock

1 USD

-0.03 (-2.91%)

Last: 10/22/2025, 8:23:19 PM

0.97 USD

-0.03 (-3%)

After Hours: 10/22/2025, 8:23:19 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CMND Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Enrolls Last Patient for the First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

2 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Enrolls Last Patient for the First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

3 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders

3 days ago - By: Clearmind Medicine Inc. - Mentions: SPRC

Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders

3 days ago - By: SciSparc Ltd - Mentions: SPRC

SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders

a month ago - By: Clearmind Medicine Inc.

Clearmind Medicine’s Convenes Inaugural Scientific Advisory Board Meeting to Advance Psychedelic-Derived Therapies

a month ago - By: Clearmind Medicine Inc.

Clearmind Medicine’s Convenes Inaugural Scientific Advisory Board Meeting to Advance Psychedelic-Derived Therapies

a month ago - By: Benzinga - Mentions: GRI BRTX ONCO MBX ...

12 Health Care Stocks Moving In Monday's Pre-Market Session

a month ago - By: Benzinga - Mentions: CPIX ABP MBX THAR ...

12 Health Care Stocks Moving In Friday's After-Market Session

a month ago - By: Clearmind Medicine Inc.

Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities

a month ago - By: Clearmind Medicine Inc.

Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

3 months ago - By: SciSparc Ltd - Mentions: SPRC -

SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

3 months ago - By: Clearmind Medicine Inc. - Mentions: SPRC

Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

3 months ago - By: Clearmind Medicine Inc. - Mentions: SPRC

Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

3 months ago - By: SciSparc Ltd - Mentions: SPRC

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

3 months ago - By: Clearmind Medicine Inc.

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled

3 months ago - By: Clearmind Medicine Inc.

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

5 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment

5 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment